McClarren Financial Advisors Inc. purchased a new position in Colgate-Palmolive (NYSE:CL – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 615 shares of the company’s stock, valued at approximately $55,000.
Other institutional investors also recently modified their holdings of the company. Union Bancaire Privee UBP SA bought a new stake in shares of Colgate-Palmolive during the 4th quarter valued at about $32,000. Hager Investment Management Services LLC acquired a new position in Colgate-Palmolive in the fourth quarter valued at approximately $36,000. Reston Wealth Management LLC bought a new position in shares of Colgate-Palmolive during the 3rd quarter worth approximately $42,000. Capital Performance Advisors LLP acquired a new stake in shares of Colgate-Palmolive during the 3rd quarter worth approximately $53,000. Finally, Synergy Asset Management LLC bought a new stake in shares of Colgate-Palmolive in the 4th quarter valued at $49,000. 80.41% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
Several brokerages recently issued reports on CL. Wells Fargo & Company cut their target price on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research note on Tuesday, January 7th. Morgan Stanley cut their price objective on shares of Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating on the stock in a research report on Monday, February 3rd. Raymond James reaffirmed an “outperform” rating and issued a $105.00 target price (down from $110.00) on shares of Colgate-Palmolive in a research report on Monday, February 3rd. Royal Bank of Canada reiterated a “sector perform” rating and issued a $101.00 price target on shares of Colgate-Palmolive in a report on Wednesday, January 29th. Finally, Stifel Nicolaus decreased their price objective on Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a report on Monday, February 3rd. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Colgate-Palmolive currently has an average rating of “Hold” and an average target price of $101.16.
Colgate-Palmolive Price Performance
Colgate-Palmolive stock opened at $86.75 on Thursday. The stock has a market cap of $70.88 billion, a P/E ratio of 24.64, a P/E/G ratio of 4.12 and a beta of 0.44. The company has a quick ratio of 0.26, a current ratio of 0.41 and a debt-to-equity ratio of 9.46. The company’s 50 day moving average price is $90.00 and its two-hundred day moving average price is $96.61. Colgate-Palmolive has a 52 week low of $82.76 and a 52 week high of $109.30.
Colgate-Palmolive (NYSE:CL – Get Free Report) last posted its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period in the previous year, the company earned $0.87 EPS. On average, equities analysts predict that Colgate-Palmolive will post 3.73 earnings per share for the current year.
Colgate-Palmolive Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a yield of 2.31%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 56.82%.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Further Reading
- Five stocks we like better than Colgate-Palmolive
- How to Plot Fibonacci Price Inflection Levels
- 3 Reasons Micron Stock Is Deeply Undervalued Right Now
- What Investors Need to Know to Beat the Market
- Inflation Persists, But So Do Stock Opportunities: Rally On
- When to Sell a Stock for Profit or Loss
- Energy Transfer Fuels the Cloud: A Natural Gas Power Play
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.